19 May 2015 14:35
Amphion Innovations plc
Appointment of Broker
London and New York, 19 May 2015 - Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, is pleased to announce the appointment of Northland Capital Partners Limited as joint corporate broker to the Company, with immediate effect.
For further information please contact
Amphion Innovations plcCharlie Morgan+1 (212) 210 6224
Yellow Jersey PRDominic Barretto / Philip Ranger/ Fiona Walker+44 7768 537 739Panmure Gordon Limited (Nominated Adviser and Joint Corporate Broker)Freddy Crossley / Duncan Monteith (Corporate Finance)Charles Leigh-Pemberton (Corporate Broking)+44 020 7886 2500
Northland Capital Partners Limited (Joint Corporate Broker) |
Gerry Beaney / David Hignell (Corporate Finance) John Howes / Mark Treharne (Corporate Broking) +44 (0) 20 7382 1100 |
Plumtree Capital Limited (Advisor to Amphion)
Stephen Austin
+44 207 183 2493
+1 646 568 7502
About Amphion Innovations plcAmphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.
On the web: www.amphionplc.com